A. Kadi

发表

Spatial localisation of curcumin and rapid screening of the chemical compositions of turmeric rhizomes (Curcuma longa Linn.) using Direct Analysis in Real Time-Mass Spectrometry (DART-MS).

A. Rahman, R. F. Angawi, A. Kadi, 2015, Food chemistry.

LC-ESI-MS/MS identification and characterization of ponatinib in vivo phase I and phase II metabolites.

A. Kadi, H. Alrabiah, H. Darwish, 2018, Clinica chimica acta; international journal of clinical chemistry.

LC-MS/MS Estimation of the Anti-Cancer Agent Tandutinib Levels in Human Liver Microsomes: Metabolic Stability Evaluation Assay

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2020, Drug design, development and therapy.

A validated stability-indicating HPLC method for determination of varenicline in its bulk and tablets

A. Kadi, I. Darwish, M. Mohamed, 2011, Chemistry Central journal.

A highly sensitive LC-MS/MS method to determine novel Bruton's tyrosine kinase inhibitor spebrutinib: application to metabolic stability evaluation

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2019, Royal Society Open Science.

RESEARCH ARTICLES Evaluation of Basic Compounding Skills of Pharmacy Students

A. Kadi, M. Hindle, W. Soine, 2005 .

In vitro Investigation of Metabolic Profiling of a Potent Topoisomerase Inhibitors Fluorescein Hydrazones (FLHs) in RLMs by LC-MS/MS.

A. Rahman, A. Kadi, Nasser S Al-Shakliah, 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

In vitro investigation of metabolic profiling of newly developed topoisomerase inhibitors (ethyl fluorescein hydrazones, EtFLHs) in RLMs by LC-MS/MS.

A. Rahman, A. Kadi, Nasser S Al-Shakliah, 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2020, Drug design, development and therapy.

1-(5-Bromo-4-phenyl-1,3-thiazol-2-yl)pyrrolidin-2-one

Tze Shyang Chia, A. Kadi, H. Fun, 2012, Acta crystallographica. Section E, Structure reports online.

A Facile Solvent Free Claisen-Schmidt Reaction: Synthesis of α,α′-bis-(Substituted-benzylidene)cycloalkanones and α,α′-bis-(Substituted-alkylidene)cycloalkanones

A. Rahman, A. Kadi, R. Ali, 2012, Molecules.

LC/MS in the Direct Characterization of Glucuronides from Biological Fluids

S. Arabia, A. Kadi, M. Hefnawy, 2008 .

Profiling of in vivo, in vitro and reactive zorifertinib metabolites using liquid chromatography ion trap mass spectrometry

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2022, RSC advances.

Nickel-catalyzed and benzoic acid-promoted direct sulfenylation of unactivated arenes.

A. Kadi, Hongjian Lu, H. Fun, 2015, Chemical communications.

LC-MS/MS method for the quantification of the anti-cancer agent infigratinib: Application for estimation of metabolic stability in human liver microsomes.

A. Kadi, H. Alrabiah, N. AlMasoud, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Metabolic Stability Assessment of Larotrectinib Using Liquid Chromatography Tandem Mass Spectrometry

A. Kadi, H. Darwish, Mohamed W. Attwa, 2020, Drug design, development and therapy.

Development and validation of an HPLC-MS/MS method for the determination of filgotinib, a selective Janus kinase 1 inhibitor: Application to a metabolic stability study.

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

DDDT_A_274118 4439..4449

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2020 .

A reliable and stable method for the determination of foretinib in human plasma by LC-MS/MS: Application to metabolic stability investigation and excretion rate

A. Kadi, H. Alrabiah, H. Darwish, 2018, European journal of mass spectrometry.

Investigation of metabolic degradation of new ALK inhibitor: Entrectinib by LC-MS/MS.

A. Kadi, H. Darwish, Mohamed W. Attwa, 2018, Clinica chimica acta; international journal of clinical chemistry.

Development and validation of an HPLC–MS/MS method for the determination of arginine-vasopressin receptor blocker conivaptan in human plasma and rat liver microsomes: application to a metabolic stability study

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2018, Chemistry Central Journal.

LC–MS/MS method for the quantification of masitinib in RLMs matrix and rat urine: application to metabolic stability and excretion rate

A. Kadi, H. Darwish, Mohamed W. Attwa, 2017, Chemistry Central Journal.

Validated LC-MS/MS Method for the Quantification of Ponatinib in Plasma: Application to Metabolic Stability

A. Kadi, H. Darwish, Mohamed W. Attwa, 2016, PloS one.

Galeon: A Biologically Active Molecule with In Silico Metabolite Prediction, In Vitro Metabolic Profiling in Rat Liver Microsomes, and In Silico Binding Mechanisms with CYP450 Isoforms

A. Rahman, A. Kadi, Y. Jahng, 2020, Molecules.

Source-Induced Dissociation Vs Collision-Induced Dissociation Fragmentation Behavior of Four Antiviral Drugs in a Liquid Chromatography Ion-Trap Mass Spectrometry Source-In-duced Dissociation Vs Collision-Induced Dissociation Fragmentation Behavior of Four Antiviral Drugs in a Liquid Chromatography

A. Kadi, Mohamed W. Attwa, Motiur Rahman, 2021 .

A highly sensitive automated flow immunosensor based on kinetic exclusion analysis for determination of the cancer marker 8-hydroxy-2′-deoxyguanosine in urine

A. Kadi, A. Al-majed, N. Y. Khalil, 2013 .

A highly efficient and sensitive LC-MS/MS method for the determination of afatinib in human plasma: application to a metabolic stability study.

A. Kadi, H. Darwish, Mohamed W. Attwa, 2016, Biomedical chromatography : BMC.

In Vitro Identification of Potential Metabolites of Plinabulin (NPI 2358) in Hepatic Preparations Using Liquid Chromatography–Ion Trap Mass Spectrometry

A. Kadi, R. Al-Salahi, Nasser S Al-Shakliah, 2022, ACS omega.

Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling

G. Piazza, A. Kadi, A. Keeton, 2017, Drug design, development and therapy.

Spectrofluorimetric study of finasteride and bovine serum albumin interaction and its application for quantitative determination of finasteride in tablet dosage form

A. Kadi, A. Alanazi, A. S. Abdelhameed, 2015 .

Detection and characterization of simvastatin and its metabolites in rat tissues and biological fluids using MALDI high resolution mass spectrometry approach

A. Kadi, Mohamed W. Attwa, Reem I. Al-Wabli, 2022, Scientific Reports.

Biophysical and In Silico Studies of the Interaction between the Anti-Viral Agents Acyclovir and Penciclovir, and Human Serum Albumin

A. Kadi, H. Alrabiah, F. Almutairi, 2017, Molecules.

Photosensitive peptide hydrogels as smart materials for applications

A. Kadi, Yan Zhang, Dongdong Wu, 2018, Chinese Chemical Letters.

Solvent free Cannizzaro reaction applying grindstone technique

A. Kadi, A. Rahman, 2016 .

Cobalt-Catalyzed Decarboxylative 2-Benzoylation of Oxazoles and Thiazoles with α-Oxocarboxylic Acids.

A. Kadi, Guigen Li, Hongjian Lu, 2015, The Journal of organic chemistry.

Liquid chromatographic-tandem mass spectrometric assay for simultaneous quantitation of tofacitinib, cabozantinib and afatinib in human plasma and urine

A. Kadi, H. Darwish, Mohamed W. Attwa, 2017 .

Nickel‐Catalyzed Decarboxylative Arylation of Heteroarenes through sp2 C–H Functionalization

A. Kadi, Hongjian Lu, H. Fun, 2014 .

Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.

Ebtehal S. Al-Abdullah, A. Kadi, A. El-Emam, 2010, European journal of medicinal chemistry.

Synthesis of Some New Heterocyclic Compounds Derived from 3-Formylchromones and Their Antimicrobial Evaluation

A. Kadi, S. Ng,, A. Bari, 2014, Chemistry of Heterocyclic Compounds.

Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles.

A. Kadi, O. Al-Deeb, A. El-Emam, 2007, European journal of medicinal chemistry.

Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.

A. Rahman, A. Kadi, H. Abdel‐Aziz, 2016, Bioorganic & medicinal chemistry.

Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives.

A. Kadi, A. El-Emam, E. S. Al-Abdullah, 2010, European journal of medicinal chemistry.

Unexpected ring-opening of 3-aroylbenzo[ b ]furans at room temperature: a new route for the construction of phenol-substituted pyrazoles

A. Kadi, H. Fun, H. Abdel‐Aziz, 2013 .

Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives.

A. Kadi, A. Alafeefy, O. Al-Deeb, 2010, European journal of medicinal chemistry.

N-[4-(4-Bromophenyl)thiazol-2-yl]-4-(piperidin-1-yl)butanamide

Tze Shyang Chia, A. Kadi, H. Fun, 2012, Acta crystallographica. Section E, Structure reports online.

Synthesis, Analgesic and Anti‐Inflammatory Evaluation of Some New 3H‐Quinazolin‐4‐one Derivatives

A. Kadi, A. Alafeefy, A. El-Azab, 2008, Archiv der Pharmazie.

Synthesis and Fragmentation Behavior Study of n-alkyl/benzyl Isatin Derivatives Present in Small/Complex Molecules: Precursor for the Preparation of Biological Active Heterocycles

A. Rahman, A. Kadi, Nasser S Al-Shakliah, 2015 .

Synthesis, biological evaluation and molecular docking studies of thiazole-based pyrrolidinones and isoindolinediones as anticonvulsant agents

R. F. Angawi, A. Kadi, H. Ghabbour, 2015, Medicinal Chemistry Research.

Synthesis, biological evaluation and molecular docking studies of thiazole-based pyrrolidinones and isoindolinediones as anticonvulsant agents

R. F. Angawi, A. Kadi, H. Ghabbour, 2015, Medicinal Chemistry Research.

New ultra-short acting hypnotic: synthesis, biological evaluation, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]diazepin-3-carboxylate (HIE-124).

J. Lehmann, A. Kadi, Ghada S. Hassan, 2008, Bioorganic & medicinal chemistry letters.

Spectroscopic investigation (FT-IR and FT-Raman), vibrational assignments, HOMO-LUMO analysis and molecular docking study of 2-(Adamantan-1-yl)-5-(4-nitrophenyl)-1,3,4-oxadiazole.

E. Tiekink, A. Kadi, S. Ng,, 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

2-(Adamantan-1-yl)-5-(4-nitrophenyl)-1,3,4-oxadiazole

E. Tiekink, A. Kadi, S. Ng,, 2012, Acta crystallographica. Section E, Structure reports online.

Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles.

A. Kadi, O. Al-Deeb, A. El-Emam, 2007, European journal of medicinal chemistry.

Microwave-Assisted Solution-Phase Synthesis and DART-Mass Spectrometric Monitoring of a Combinatorial Library of Indolin-2,3-dione Schiff Bases with Potential Antimycobacterial Activity

A. Kadi, H. Abdel‐Aziz, T. Aboul-Fadl, 2011, Molecules.

Microwave-Assisted One-Step Synthesis of Fenamic Acid Hydrazides from the Corresponding Acids

A. Kadi, S. Ng,, A. Bari, 2011, Molecules.

RETRACTED: Synthesis and antimicrobial activity of some new quinazolin-4(3H)-one derivatives

A. Kadi, 2011, Journal of Saudi Chemical Society.

N′-(Adamantan-2-ylidene)thiophene-2-carbohydrazide

E. Tiekink, A. Kadi, S. Ng,, 2011, Acta crystallographica. Section E, Structure reports online.

Induced in-source fragmentation pattern of certain novel (1Z,2E)-N-(aryl)propanehydrazonoyl chlorides by electrospray mass spectrometry (ESI-MS/MS)

A. Kadi, H. Abdel‐Aziz, Mohamed W. Attwa, 2013, Chemistry Central Journal.

In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling

A. Kadi, Hatem A. Abuelizz, H. Darwish, 2020, RSC Advances.

Fluorescein hydrazones as novel nonintercalative topoisomerase catalytic inhibitors with low DNA toxicity.

A. Rahman, A. Kadi, Youngjoo Kwon, 2014, Journal of medicinal chemistry.

High Throughput Quantitative Bioanalytical LC/MS/MS Determination of Gemifloxacin in Human Urine

R. F. Angawi, A. Kadi, H. Darwish, 2013 .

A Preliminary Study of Arecoline and Guvacoline Presence in the Saliva of a “Betel-Quid” Chewer Using Liquid-Chromatography Ion Trap Mass Spectrometry

A. Kadi, Mohamed W. Attwa, A. Rahman, 2013, European Journal of Mass Spectrometry.

An LC-MS/MS method for rapid and sensitive high-throughput simultaneous determination of various protein kinase inhibitors in human plasma.

A. Kadi, Mohamed W. Attwa, Ali S Abdelhameed, 2017, Biomedical chromatography : BMC.

Fragmentation pattern of certain isatin–indole antiproliferative conjugates with application to identify their in vitro metabolic profiles in rat liver microsomes by liquid chromatography tandem mass spectrometry

A. Kadi, Mohamed W. Attwa, Reem I. Al-Wabli, 2020 .

Synthesis and anticonvulsant activity of some new thiazolo[3,2-a][1,3]diazepine, benzo[d]thiazolo[5,2-a][12,6]diazepine and benzo[d]oxazolo[5,2-a][12,6]diazepine analogues.

A. Kadi, Ghada S. Hassan, M. Sayed-Ahmed, 2011, European journal of medicinal chemistry.

Labeling and biodistribution of 99mTc-7-bromo-1,4-dihydro-4-oxo-quinolin-3-carboxylic acid complex

A. Kadi, Reem I. Al-Wabli, W. Zaghary, 2011 .

Fragmentation Behavior Studies of Chalcones Employing Direct Analysis in Real Time (DART)

S. Arabia, A. Kadi, P. Ahmad, 2013 .

Molecular platforms based on biocompatible photoreactions for photomodulation of biological targets.

A. Kadi, Jinbo Li, Yan Zhang, 2021, Organic & biomolecular chemistry.

Liquid chromatographic high-throughput analysis of the new ultra-short acting hypnotic 'HIE-124' and its metabolite in mice serum using a monolithic silica column.

A. Kadi, Y. Asiri, S. Attia, 2011, The Analyst.

Synthesis and Photophysical Properties of Fluorescein Esters as Potential Organic Semiconductor Materials

A. Kadi, H. Alrabiah, G. Mostafa, 2021, Journal of Fluorescence.

Fluorescein hydrazones: A series of novel non-intercalative topoisomerase IIα catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells.

A. Kadi, M. Islam, Seojeong Park, 2017, European journal of medicinal chemistry.

Effective quantification of ravidasvir (an NS5A inhibitor) and sofosbuvir in rat plasma by validated LC-MS/MS method and its application to pharmacokinetic study

A. Kadi, Sherif F Hammad, Mohamed W. Attwa, 2020 .

Linear diarylheptanoids as potential anticancer therapeutics: synthesis, biological evaluation, and structure–activity relationship studies

A. Kadi, Y. Jahng, H. Cha, 2018, Archives of Pharmacal Research.

Linear diarylheptanoids as potential anticancer therapeutics: synthesis, biological evaluation, and structure–activity relationship studies

A. Kadi, Y. Jahng, H. Cha, 2018, Archives of pharmacal research.

LC–MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2021, Drug design, development and therapy.

DDDT_A_321330 3915..3925

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2021 .

Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC–MS/MS: in vitro metabolic investigation

A. Kadi, Hatem A. Abuelizz, H. Darwish, 2019, Royal Society Open Science.

Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometry

A. Kadi, H. Darwish, Mohamed W. Attwa, 2018, Chemistry Central Journal.

LC-MS/MS reveals the formation of aldehydes and iminium reactive intermediates in foretinib metabolism: phase I metabolic profiling

A. Kadi, H. Darwish, Mohamed W. Attwa, 2017 .

Synthesis, molecular docking and antibacterial evaluation of various quinoline schiff bases: labeling and biodistribution of 99mTc-2-(p-hydroxybenzylidene)-1-(quinolin-4-yl) hydrazine

A. Kadi, M. Khedr, Reem I. Al-Wabli, 2014, Medicinal Chemistry Research.

Detection and characterization of ponatinib reactive metabolites by liquid chromatography tandem mass spectrometry and elucidation of bioactivation pathways

A. Kadi, H. Darwish, Mohamed W. Attwa, 2016 .

Synthesis, Ultra‐Short Acting Hypnotic Activity, and Metabolic Profile of Ethyl 8‐Oxo‐5,6,7,8‐tetrahydro‐thiazolo[3,2‐a] [1,3]diazepin‐3‐carboxylate (HIE‐124)

J. Lehmann, A. Kadi, Ghada S. Hassan, 2008, Archiv der Pharmazie.

Identification of Iminium Intermediates Generation in the Metabolism of Tepotinib Using LC-MS/MS: In Silico and Practical Approaches to Bioactivation Pathway Elucidation

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2020, Molecules.

EGFR Inhibitor Gefitinib Induces Cardiotoxicity through the Modulation of Cardiac PTEN/Akt/FoxO3a Pathway and Reactive Metabolites Formation: In Vivo and In Vitro Rat Studies.

A. Kadi, H. Korashy, A. Zeidan, 2020, Chemical research in toxicology.

Liquid chromatography–tandem mass spectrometry metabolic profiling of nazartinib reveals the formation of unexpected reactive metabolites

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2019, Royal Society Open Science.

Belizatinib: Novel reactive intermediates and bioactivation pathways characterized by LC-MS/MS.

A. Kadi, H. Darwish, Mohamed W. Attwa, 2019, Journal of pharmaceutical and biomedical analysis.

Reactive intermediates and bioactivation pathways characterization of avitinib by LC–MS/MS: In vitro metabolic investigation

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2019, Journal of pharmaceutical and biomedical analysis.

LC–MS/MS reveals the formation of iminium and quinone methide reactive intermediates in entrectinib metabolism: In vivo and in vitro metabolic investigation

A. Kadi, H. Alrabiah, H. Darwish, 2018, Journal of pharmaceutical and biomedical analysis.

Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC–ESI–MS/MS

A. Kadi, H. Darwish, Mohamed W. Attwa, 2018, Chemistry Central Journal.

LC-MS/MS reveals the formation of reactive ortho-quinone and iminium intermediates in saracatinib metabolism: Phase I metabolic profiling.

A. Kadi, H. Alrabiah, H. Darwish, 2018, Clinica chimica acta; international journal of clinical chemistry.

Development and Validation of a Rapid LC-MS/MS Method for Quantifying Alvocidib: In Silico and In Vitro Metabolic Stability Estimation in Human Liver Microsomes

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2023, Molecules.

Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2023, Molecules.

Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies

A. Kadi, Mohamed W. Attwa, H. Alhazmi, 2020, Drug design, development and therapy.

Phase I metabolic profiling and unexpected reactive metabolites in human liver microsome incubations of X-376 using LC-MS/MS: bioactivation pathway elucidation and in silico toxicity studies of its metabolites

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2020, RSC advances.

Detection and characterization of olmutinib reactive metabolites by LC-MS/MS: Elucidation of bioactivation pathways.

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2019, Journal of separation science.

Validated LC-MS/MS assay for quantification of the newly approved tyrosine kinase inhibitor, dacomitinib, and application to investigating its metabolic stability

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2019, PloS one.

Liquid chromatography tandem mass spectrometry method for the quantification of vandetanib in human plasma and rat liver microsomes matrices: metabolic stability investigation

A. Kadi, H. Darwish, Mohamed W. Attwa, 2017, Chemistry Central Journal.

Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2023, Molecules.

A validated LC-MS/MS analytical method for the quantification of pemigatinib: metabolic stability evaluation in human liver microsomes

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2022, RSC advances.

A simple liquid chromatography-tandem mass spectrometry method to accurately determine the novel third-generation EGFR-TKI naquotinib with its applicability to metabolic stability assessment

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2019, RSC advances.

Synthesis, biological evaluation and Structure Activity Relationships (SARs) study of 8-(substituted)aryloxycaffeine

A. Kadi, Y. Jahng, K. Eltahir, 2015 .

Investigation of the metabolic stability of olmutinib by validated LC-MS/MS: quantification in human plasma

A. Kadi, H. Darwish, Mohamed W. Attwa, 2018, RSC advances.

Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics.

A. Kadi, Y. Jahng, M. Alam, 2019, Anti-cancer agents in medicinal chemistry.

Estimation of zorifertinib metabolic stability in human liver microsomes using LC-MS/MS.

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2022, Journal of pharmaceutical and biomedical analysis.

Pseudo-MS3 Approach Using Electrospray Mass Spectrometry (ESI-MS/MS) to Characterize Certain (2E)-2-[3-(1H-Imidazol-1-yl)-1-phenylpropylidene]hydrazinecarboxamide Derivatives

R. F. Angawi, A. Kadi, H. Darwish, 2014 .

Multistage Fragmentation of Ion Trap Mass Spectrometry System and Pseudo-MS3 of Triple Quadrupole Mass Spectrometry Characterize Certain (E)-3-(Dimethylamino)-1-arylprop-2-en-1-ones: A Comparative Study

R. F. Angawi, A. Kadi, H. Abdel‐Aziz, 2014, TheScientificWorldJournal.

Liquid chromatographic-mass spectrometric method for determination of drug content uniformity of two commonly used dermatology medications in a split-tablet dosage form

R. F. Angawi, A. Kadi, Mohamed W. Attwa, 2016 .

Exploring the effect of khat (Catha edulis) chewing on the pharmacokinetics of the antiplatelet drug clopidogrel in rats using the newly developed LC-MS/MS technique

A. Kadi, A. Khalid, Mohamed W. Attwa, 2020 .

A New Validated HPLC-MS/MS Method for Quantification and Pharmacokinetic Evaluation of Dovitinib, a Multi-Kinase Inhibitor, in Mouse Plasma

A. Kadi, H. Alrabiah, S. Attia, 2020, Drug design, development and therapy.

DDDT_A_223573 407..415

A. Kadi, H. Alrabiah, S. Attia, 2020 .

A Validated LC–MS/MS Assay for the Simultaneous Quantification of the FDA-Approved Anticancer Mixture (Encorafenib and Binimetinib): Metabolic Stability Estimation

A. Kadi, H. Darwish, Mohamed W. Attwa, 2021, Molecules.

Sample stacking microemulsion electrokinetic capillary chromatography induced by reverse migrating pseudostationary phase for the quantification of phenobarbital and its p-hydroxyphenobarbital metabolite in rat urine.

A. Kadi, M. Abounassif, S. Attia, 2011, The Analyst.

Characterization of reactive intermediates formation in dacomitinib metabolism and bioactivation pathways elucidation by LC-MS/MS: in vitro phase I metabolic investigation

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2018, RSC advances.

Development and validation of HPLC-MS/MS method for the determination of lixivaptan in mouse plasma and its application in a pharmacokinetic study.

A. Kadi, H. Alrabiah, S. Attia, 2017, Biomedical chromatography : BMC.

Structural, spectroscopic, Hirshfeld surface and charge distribution analysis of 3-(1H-imidazole-1-yl)-1-phenylpropan-1-ol complemented by molecular docking predictions: An integrated experimental and computational approach

A. Kadi, S. Sebastian, S. Periandy, 2019, Journal of Molecular Structure.

Identification and characterization of in vitro, in vivo, and reactive metabolites of tandutinib using liquid chromatography ion trap mass spectrometry.

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2021, Analytical methods : advancing methods and applications.

Identification and characterization of in vitro phase I and reactive metabolites of masitinib using a LC-MS/MS method: bioactivation pathway elucidation

A. Kadi, H. Darwish, Mohamed W. Attwa, 2017 .

Simvastatin: In Vitro Metabolic Profiling of a Potent Competitive HMG-CoA Reductase Inhibitor

A. Kadi, Mohamed W. Attwa, Wencui Yin, 2022, Separations.

Rapid validated liquid chromatographic method coupled with Tandem mass spectrometry for quantification of nintedanib in human plasma

A. Kadi, H. Darwish, Mohamed W. Attwa, 2016 .

LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways

A. Kadi, H. Darwish, Mohamed W. Attwa, 2018, RSC advances.

Investigation of metabolic stability of the novel ALK inhibitor brigatinib by liquid chromatography tandem mass spectrometry.

A. Kadi, H. Darwish, Mohamed W. Attwa, 2018, Clinica chimica acta; international journal of clinical chemistry.

An UPLC–ESI–MS/MS Bioanalytical Methodology for the Quantification of Gilteritinib in Human Liver Microsomes: Application to In Vitro and In Silico Metabolic Stability Estimation

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2023, Separations.

Enzyme-instructed self-assembly with photo-responses for the photo-regulation of cancer cells.

A. Kadi, Jinbo Li, Yan Zhang, 2017, Organic & biomolecular chemistry.

A photo-degradable supramolecular hydrogel for selective delivery of microRNA into 3D-cultured cells.

A. Kadi, Jinbo Li, Yan Zhang, 2017, Organic & biomolecular chemistry.

Reactive intermediates in naquotinib metabolism identified by liquid chromatography-tandem mass spectrometry: phase I metabolic profiling

A. Kadi, H. Alrabiah, H. Darwish, 2019, RSC advances.

Exploring the Chemical Reactivity, Molecular Docking, Molecular Dynamic Simulation and ADMET Properties of a Tetrahydrothienopyridine Derivative Using Computational Methods

A. Kadi, H. Alkahtani, H. Ghabbour, 2023, Crystals.

Somophilic Isocyanide Insertion: Synthesis of 6-Arylated and 6-Trifluoromethylated Phenanthridines

A. Kadi, H. Fun, Shouyun Yu, 2014, Synthesis.

Optimized HILIC-MS/MS Method for Simultaneous Determination of two Antiepileptic Drugs with Significant Difference in Binding to Serum Albumin

A. Kadi, H. Makeen, H. Alhazmi, 2016 .

Piperazine ring toxicity in three novel anti-breast cancer drugs: an in silico and in vitro metabolic bioactivation approach using olaparib as a case study

A. Kadi, Hatem A. Abuelizz, H. Darwish, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology.

A Sensitive, Green, and Fast LC–MS/MS Analytical Method for the Quantification of Ribociclib: Evaluation of the Metabolic Stability in HLMs

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2023, Separations.

An LC–MS/MS Analytical Method for Quantifying Tepotinib in Human Liver Microsomes: Application to In Vitro and In Silico Metabolic Stability Estimation

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2023, Separations.

A Fast LC-MS/MS Methodology for Estimating Savolitinib in Human Liver Microsomes: Assessment of Metabolic Stability Using In Vitro Metabolic Incubation and In Silico Software Analysis

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2023, Separations.

Development of a Fast and Sensitive UPLC–MS/MS Analytical Methodology for Fenebrutinib Estimation in Human Liver Microsomes: In Vitro and In Silico Metabolic Stability Evaluation

A. Kadi, Mohamed W. Attwa, A. S. Abdelhameed, 2023, Separations.

LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways

A. Kadi, H. Darwish, Mohamed W. Attwa, 2018, RSC advances.

Sapitinib: reactive intermediates and bioactivation pathways characterized by LC-MS/MS

A. Kadi, Mohamed W. Attwa, 2019, RSC advances.

Reactive intermediates in copanlisib metabolism identified by LC-MS/MS: phase I metabolic profiling

A. Kadi, H. Alrabiah, Mohamed W. Attwa, 2019, RSC advances.

Characterization of the in vitro metabolic profile of nazartinib in HLMs using UPLC-MS/MS method: In silico metabolic lability and DEREK structural alerts screening using StarDrop software

A. Kadi, Mohamed W. Attwa, A. Abdelhameed, 2024, Heliyon.